We use cookies to enhance your experience.
By clicking "Accept All", you consent to the use of all cookies.
Customize your preferences or read our Cookie Policy.
The U.S. interventional oncology market is expected to reach USD 8.5 billion by 2028, growing at a CAGR of 7.8% from 2021 to 2028. The increasing prevalence of cancer, advancements in interventional oncology techniques, and a growing preference for minimally invasive procedures drive this growth.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.